JP2015128432A - Method for producing isolated sheet-like cell culture - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a method for isolating sheet-like cell culture simply and highly efficiently which is used for repairing injured tissues or the like.SOLUTION: A method for producing isolated sheet-like cell culture comprises: freezing the sheet-like cell culture formed by culturing cells seeded on a culture substrate for a period within 24 hours in a condition of adhering to the culture substrate; thawing the freezed sheet-like cell culture by immersing into a medium at 30°C-40°C; and isolating the sheet-like cell culture from the culture substrate. Further, the method for producing the sheet-like cell culture comprises adding a cryopreservation agent to the culture medium, and/or replacing the culture medium by a cryopreservation liquid.

Description

  The present invention relates to a method for producing an isolated sheet-shaped cell culture, a sheet-shaped cell culture produced thereby, a method for promoting the isolation of a sheet-shaped cell culture, a method for preserving a sheet-shaped cell culture, and the like.

  In recent years, attempts have been made to transplant various cells in order to repair damaged tissues and the like. For example, in order to repair myocardial tissue damaged by ischemic heart disease such as angina pectoris and myocardial infarction, attempts have been made to use fetal myocardial cells, skeletal myoblasts, ES cells, and the like. However, when transplanted cells are administered to a tissue in the form of a cell suspension, there are problems such as low infusion efficiency of transplanted cells, risk of damaging the recipient tissue, and difficulty in extensive tissue repair. Therefore, a cell structure formed using a scaffold and a cell sheet in which cells are formed in a sheet shape have been developed. Regarding the application of cell sheets to treatment, the use of cultured epidermal sheets for skin damage due to burns, use of corneal epithelial cell sheets for corneal damage, use of oral mucosal cell sheets for endoscopic resection of esophageal cancer, etc. It is being advanced.

  The cell sheet is generally formed by culturing cells in a sheet form on a culture substrate. However, when actually used for treatment, it is necessary to isolate the formed cell sheet from the culture substrate. As a specific isolation method, a method using a proteolytic enzyme such as trypsin or a method of mechanically peeling with a scraper or pipette is generally used. However, these techniques have problems such as damage to the cell sheet and a decrease in cell viability. Therefore, attempts have been made to improve the isolation of the cell sheet by modifying the material and structure of the culture substrate. ing. For example, Patent Document 1 discloses the use of a culture substrate coated with a temperature-responsive polymer, Patent Document 2 discloses the use of a culture substrate having a plurality of minute irregularities, and Patent Document 3 discloses that The use of culture substrates coated with fibrin is described respectively. However, the culture substrate coated with a temperature-responsive polymer and the culture substrate described in Patent Document 2 are expensive, and the culture substrate coated with fibrin is feared to be adversely affected by the remaining fibrin. Therefore, there has been a demand for a technique that can easily and efficiently isolate a cell sheet without such problems.

Special Table 2007-528755 JP 2008-11766 JP 2009-11322

  The object of the present invention is to provide a simple and highly efficient method for isolating a sheet-shaped cell culture that does not have the problems of the prior art.

  In the course of diligent research to solve the above problems, the present inventors frozen a sheet-shaped cell culture while attached to a culture substrate, and then thawed it to obtain a normal culture medium. It was found that the sheet-shaped cell culture can be easily isolated from the base material even when using the material, and the survival rate of the cells constituting the obtained isolated sheet-shaped cell culture is high. Was completed.

Therefore, this invention is shown by the following (1)-(10).
(1) A step of freezing a sheet-like cell culture formed on a culture substrate while attached to the culture substrate;
Thawing the frozen sheet-shaped cell culture, and isolating the sheet-shaped cell culture from the culture substrate;
A process for producing an isolated sheet-shaped cell culture.
(2) The method according to (1), further comprising a step of seeding cells on the culture substrate at a density capable of forming a sheet-shaped cell culture without substantially growing.
(3) The method according to (1) or (2), further comprising a step of culturing cells on a culture substrate to form a sheet-shaped cell culture.
(4) The method according to any one of (1) to (3), further comprising a step of adding a cryopreservation agent to the culture solution and / or a step of replacing the culture solution with a cryopreservation solution.
(5) The method according to any one of (1) to (4), wherein the culture substrate has cell adhesion.
(6) An isolated sheet-shaped cell culture produced by the method according to any one of (1) to (5).
(7) A sheet-like cell comprising a step of freezing a sheet-like cell culture formed on a culture substrate while attached to the culture substrate, and a step of thawing the frozen sheet-like cell culture. A method for promoting the isolation of a culture.
(8) A sheet-shaped cell culture frozen in a state of adhering to the culture substrate.
(9) A culture substrate comprising a sheet-shaped cell culture frozen in a state of adhering to the substrate surface.
(10) A method for preserving a sheet-shaped cell culture, comprising a step of freezing the sheet-shaped cell culture formed on the culture substrate while attached to the culture substrate.

According to the method of the present invention, since a sheet-like cell culture can be isolated without using a proteolytic enzyme or a special culture substrate, an isolated sheet-like cell culture, particularly myoblasts, The acquisition of a sheet-shaped cell culture composed of cells with weak cell-binding ability is made more efficient, and the quality, safety and economics of the obtained isolated sheet-shaped cell culture are improved. Treatment using culture is promoted.
In addition, when using a culture substrate coated with a temperature-responsive polymer, the sheet-shaped cell culture can be easily collected without pipetting, so it can be used at room temperature, which was conventionally required. There is an advantage that contamination of the sheet and damage to the sheet due to pipetting operations can be avoided.
Furthermore, according to the method of the present invention, the sheet-like cell culture can be stored for a long time in a state where it can be easily isolated with high recovery rate and high viability, and can be easily stored and transported. Since it can be isolated, it can be stored in the state of a sheet-shaped cell culture in advance, and it becomes possible to transplant the sheet-shaped cell culture whenever necessary. .

FIG. 1 is a photograph showing the result of attempting to isolate a sheet-like cell culture formed on a normal culture substrate by pipetting. FIG. 2 is a photograph showing an isolated sheet-shaped cell culture obtained by freezing and thawing a sheet-shaped cell culture formed on a temperature-responsive culture dish. FIG. 3 is a photograph showing an isolated sheet-shaped cell culture obtained by freezing and thawing a sheet-shaped cell culture formed on a normal culture dish.

The present invention includes a step of freezing a sheet-like cell culture formed on a culture substrate while attached to the culture substrate;
The present invention relates to a method for producing an isolated sheet-shaped cell culture, comprising a step of thawing a frozen sheet-shaped cell culture and a step of peeling the sheet-shaped cell culture from a culture substrate.

  The cells used in the production method of the present invention include any cells that can form a sheet-like cell culture. Examples of such cells include, but are not limited to, myoblasts (eg, skeletal myoblasts), cardiomyocytes, fibroblasts, synovial cells, epithelial cells, endothelial cells, and the like. Among these, in the present invention, those that form a monolayer cell culture, such as myoblasts, are preferred. The cells can be derived from any organism capable of being treated with cell culture. Such organisms include, but are not limited to, humans, non-human primates, dogs, cats, pigs, horses, goats, sheep and the like. Further, only one type of cell may be used in the method of the present invention, but two or more types of cells can also be used. In a preferred embodiment of the present invention, when there are two or more types of cells forming a cell culture, the most cell ratio (purity) is 65% or more, preferably 70% or more at the end of cell culture production. Preferably it is 75% or more.

  In the present invention, the “sheet-shaped cell culture” refers to a sheet in which cells are connected to each other and is typically composed of one cell layer, but is composed of two or more cell layers. Including those that are made. The cells may be linked to each other directly and / or via an intervening substance. The intervening substance is not particularly limited as long as it is a substance capable of mechanically connecting cells to each other, and examples thereof include an extracellular matrix. The intervening substance is preferably derived from cells, in particular, derived from the cells constituting the cell culture. The cells are at least mechanically linked, but may be further functionally, eg, chemically or electrically linked.

  The sheet-shaped cell culture of the present invention preferably does not contain a scaffold (support). Scaffolds may be used in the art to attach cells on and / or within its surface and maintain the physical integrity of the cell culture, eg, polyvinylidene difluoride (PVDF) Although manufactured membranes are known, the cell culture of the present invention can maintain its physical integrity even without such a scaffold. In addition, the cell culture of the present invention preferably consists only of substances derived from the cells constituting the cell culture and does not contain any other substances.

In the present invention, the “culture substrate” is not particularly limited as long as cells can form a cell culture thereon, and examples thereof include containers of various materials, solid or semi-solid surfaces in containers, and the like. including. The container preferably has a structure / material that does not allow permeation of a liquid such as a culture solution. Examples of such materials include, but are not limited to, polyethylene, polypropylene, Teflon (registered trademark), polyethylene terephthalate, polymethyl methacrylate, nylon 6,6, polyvinyl alcohol, cellulose, silicon, polystyrene, glass, polyacrylamide, polydimethyl. Examples include acrylamide and metals (for example, iron, stainless steel, aluminum, copper, brass). The container preferably has at least one flat surface. Examples of such containers include, but are not limited to, cell culture dishes and cell culture bottles. Further, the container may have a solid or semi-solid surface therein. Examples of solid surfaces include plates and containers of various materials as described above, and examples of semi-solid surfaces include gels and soft polymer matrices. The culture substrate may be prepared using the above materials, or commercially available materials may be used. Preferable culture substrates include, but are not limited to, substrates having an adhesive surface suitable for the formation of sheet cell cultures. Specifically, a substrate having a hydrophilic surface, for example, a substrate coated with a hydrophilic compound such as polystyrene subjected to corona discharge treatment, collagen gel or hydrophilic polymer, and further, collagen, fibronectin, laminin , Substrates coated with an extracellular matrix such as vitronectin, proteoglycan and glycosaminoglycan, and cell adhesion factors such as cadherin family, selectin family and integrin family. Such a substrate is commercially available (for example, Corning ^(R) TC-Treated Culture Dish, manufactured by Corning).

The surface of the culture substrate may be coated with a material whose physical properties change in response to stimulation, for example, temperature or light. Examples of such materials include, but are not limited to, (meth) acrylamide compounds, N-alkyl substituted (meth) acrylamide derivatives (for example, N-ethylacrylamide, Nn-propylacrylamide, Nn-propylmethacrylamide, N-isopropylacrylamide, N-isopropylmethacrylamide, N-cyclopropylacrylamide, N-cyclopropylmethacrylamide, N-ethoxyethylacrylamide, N-ethoxyethylmethacrylamide, N-tetrahydrofurfurylacrylamide, N-tetrahydrofurfurylmethacrylate Amides), N, N-dialkyl-substituted (meth) acrylamide derivatives (eg, N, N-dimethyl (meth) acrylamide, N, N-ethylmethylacrylamide, N, N-diethyl) Chloramide and the like), (meth) acrylamide derivatives having a cyclic group (for example, 1- (1-oxo-2-propenyl) -pyrrolidine, 1- (1-oxo-2-propenyl) -piperidine, 4- (1-oxo -2-propenyl) -morpholine, 1- (1-oxo-2-methyl-2-propenyl) -pyrrolidine, 1- (1-oxo-2-methyl-2-propenyl) -piperidine, 4- (1-oxo -2-methyl-2-propenyl) -morpholine), or a vinyl ether derivative (for example, methyl vinyl ether) homopolymer or copolymer, a temperature-responsive material, a light-absorbing polymer having an azobenzene group, triphenylmethane leucohydro Copolymer of vinyl derivative of oxide and acrylamide monomer, and spirobenzopyra It can be used to include N- and isopropyl acrylamide gels known, such as photoresponsive materials (e.g., JP-A-2-211865, see JP-2003-33177). By giving a predetermined stimulus to these materials, the physical properties, for example, hydrophilicity and hydrophobicity can be changed, and peeling of the cell culture adhered on the materials can be promoted.
The culture substrate may have various shapes, but is preferably flat. Although the area is not particularly limited, typically, 1～200Cm ^2, preferably 2～100Cm ^2, more preferably 3~50cm ^2.

The culture substrate may be coated (coated or coated) with serum. By using a culture substrate coated with serum, a denser sheet-shaped cell culture can be formed. “Coated with serum” means a state in which serum components are attached to the surface of a culture substrate. Such a state is not limited, and can be obtained, for example, by incubating a culture substrate with serum. Incubating includes contacting the serum with a culture substrate. As the serum, heterologous serum and allogeneic serum can be used. Xenogeneic serum refers to serum derived from a different species of organism than the recipient when the cell culture is used for transplantation. For example, when the recipient is a human, serum derived from bovine or horse, for example, fetal calf serum (FBS, FCS), calf serum (CS), horse serum (HS), etc. corresponds to the heterologous serum. “Allogeneic serum” means serum derived from the same species of organism as the recipient. For example, when the recipient is a human, human serum corresponds to allogeneic serum. Allogeneic serum includes autologous serum, ie serum derived from the recipient, and allogeneic serum derived from allogeneic individuals other than the recipient. In the present specification, sera other than autoserum, that is, heterologous serum and allogeneic sera are sometimes collectively referred to as non-self serum.
Serum for coating the culture substrate is commercially available or can be prepared from blood collected from a desired organism by a conventional method. Specifically, for example, the collected blood is allowed to stand at room temperature for about 20 to 60 minutes to be coagulated, centrifuged at about 1000 to 1200 × g, and the supernatant is collected.

When incubating on a culture substrate, serum may be used as a stock solution or diluted. Dilution can be any medium such as, without limitation, water, saline, various buffers (eg, PBS, HBS, etc.), various liquid media (eg, DMEM, MEM, F12, DME, RPMI 1640, MCDB (MCDB102, 104, 107, 131, 153, 199, etc.), L15, SkBM, RITC80-7, DMEM / F12, etc.) can be used. The dilution concentration is not particularly limited as long as the serum component can adhere to the culture substrate. For example, the dilution concentration is 0.5 to 90% (v / v), preferably 1 to 60% (v / v), and more preferably. Is 5-40% (v / v).
The incubation time is not particularly limited as long as the serum component can adhere to the culture substrate. For example, the incubation time is 1 to 72 hours, preferably 4 to 48 hours, more preferably 5 to 24 hours, and further preferably 6 to 12 hours. It's time. The incubation temperature is not particularly limited as long as the serum component can adhere to the culture substrate, and is, for example, 0 to 60 ° C, preferably 4 to 45 ° C, more preferably room temperature to 40 ° C.

  Serum may be discarded after incubation. As a method for discarding serum, a conventional liquid disposal method such as suction with a pipette or decantation can be used. In a preferred embodiment of the present invention, the culture substrate may be washed with a serum-free washing solution after serum is discarded. The serum-free washing solution is not particularly limited as long as it is a liquid medium that does not contain serum and does not adversely affect the serum components attached to the culture substrate. For example, without limitation, water, physiological saline, various buffers Liquid (for example, PBS, HBS, etc.), various liquid media (for example, DMEM, MEM, F12, DME, RPMI 1640, MCDB (MCDB102, 104, 107, 131, 153, 199, etc.), L15, SkBM, RITC80-7 , DMEM / F12, etc.). As the washing method, a conventional culture substrate washing method, for example, without limitation, a method of adding a serum-free washing solution on the culture substrate, stirring for a predetermined time (for example, 5 to 60 seconds), and then discarding it is used. be able to.

  In the present invention, the culture substrate may be coated with a growth factor. As used herein, “growth factor” means any substance that promotes cell proliferation as compared to the case without it, such as epithelial cell growth factor (EGF), vascular endothelial growth factor (VEGF), fibroblast, and the like. Cell growth factor (FGF) and the like. The culture substrate coating method, the discarding method and the washing method using a growth factor have a dilution concentration at the time of incubation of, for example, 0.0001 μg / mL to 1 μg / mL, preferably 0.0005 μg / mL to 0.05 μg / mL, More preferably, it is basically the same as serum except that it is 0.001 μg / mL to 0.01 μg / mL.

  In the present invention, the culture substrate may be coated with a steroid agent. Here, the “steroid component” refers to a compound having a steroid nucleus that can adversely affect a living body such as adrenal cortex dysfunction and Cushing's syndrome. Such compounds include, but are not limited to, for example, cortisol, prednisolone, triamcinolone, dexamethasone, betamethasone and the like. The culture substrate coating method, discarding method, and washing method using a steroid agent have a dilution concentration at the time of incubation of, for example, 0.1 μg / mL to 100 μg / mL, preferably 0.4 μg / mL to 40 μg / mL. It is basically the same as serum except that the dose is 1 μg / mL to 10 μg / mL.

  The culture substrate may be coated with any one of serum, growth factor and steroid agent, any combination of these: serum and growth factor, serum and steroid agent, serum and growth factor and steroid agent, Alternatively, it may be coated with a combination of a growth factor and a steroid. When coating with a plurality of components, these components may be mixed and coated simultaneously, or may be coated in separate steps.

  The culture substrate may be seeded with cells immediately after coating with serum or the like, or may be stored after coating and then seeded with cells. The coated substrate can be stored for a long period of time by keeping it at, for example, 4 ° C. or lower, preferably −20 ° C. or lower, more preferably −80 ° C. or lower.

  In the production method of the present invention, the freezing can be performed by a normal cell freezing technique. Typically, for example, the sheet-shaped cell culture is left attached to the culture substrate, and a freezing means such as a freezer is used. It is achieved by subjecting to a deep freezer, a low-temperature medium (for example, liquid nitrogen, etc.), but is not limited thereto. The temperature of the freezing means is not particularly limited as long as it is a temperature at which a part of the sheet-like cell culture, preferably the whole, can be frozen, but is typically 0 ° C. or lower, preferably −20 ° C. or lower, more preferably − 40 ° C. or lower, more preferably −80 ° C. or lower. Further, the cooling rate in the freezing operation is not particularly limited as long as it does not significantly impair the viability and function of the cells after freezing and thawing. The cooling rate is on the order of time, preferably 2 to 4 hours, especially about 3 hours. Specifically, for example, cooling can be performed at a rate of 0.46 ° C./min. Such a cooling rate can be achieved by providing the culture substrate with the sheet-like cell culture adhered thereto directly or in a freezing treatment container while being provided in a freezing means set to a desired temperature.

  The freezing operation may be performed while the sheet-shaped cell culture is immersed in the culture solution, but a cryoprotectant is added to the culture solution to protect the cells constituting the sheet-shaped cell culture from the freezing and thawing operations. Alternatively, the culture solution can be replaced with a cryopreservation solution containing a cryoprotectant. Therefore, the production method of the present invention may further include a step of adding a cryoprotectant to the culture solution or a step of replacing the culture solution with a cryopreservation solution. When replacing the culture solution with a cryopreservation solution, if the solution in which the sheet-shaped cell culture is immersed at the time of freezing contains an effective concentration of cryoprotectant, remove the culture solution after substantially removing it. Even if the preservation solution is added, the cryopreservation solution may be added while leaving a part of the culture solution. Here, the “effective concentration” means that the cryoprotectant exhibits a cryoprotective effect without exhibiting toxicity, for example, the viability, vitality, and function of the cell after freeze-thawing compared to the case where the cryoprotectant is not used. This means a concentration that exhibits a decrease-suppressing effect.

  The cryoprotectant used in the production method of the present invention is not particularly limited as long as it exhibits a cryoprotective action on cells. For example, dimethyl sulfoxide (DMSO), glycerol, ethylene glycol, propylene glycol, sericin, propane Examples include diol, dextran, polyvinylpyrrolidone, polyvinyl alcohol, hydroxyethyl starch, chondroitin sulfate, polyethylene glycol, formamide, acetamide, adonitol, perseitol, raffinose, lactose, trehalose, sucrose, mannitol and the like. Cryoprotectants may be used alone or in combination of two or more.

The concentration of the cryoprotectant added to the culture solution or the concentration of the cryoprotectant in the cryopreservation solution is not particularly limited as long as it is an effective concentration as defined above. It is 2 to 20% (v / v) with respect to the whole preservation solution. However, although outside this concentration range, alternative use concentrations known or experimentally determined for each cryoprotectant may be employed, and such concentrations are within the scope of the present invention.
The amount of culture solution (with or without cryoprotectant) or cryopreservation solution during the freezing operation can completely immerse the sheet-shaped cell culture (ie, the culture medium to which the sheet-shaped cell culture is attached). When the material is subjected to freezing means, the cell-shaped cell culture can be completely covered with a cryopreservation solution), and is not particularly limited as long as it can be thawed within a predetermined time. If it is a sheet-like cell culture formed with cells, it is typically, for example, 20 to 200 μL / cm ^{2 with} respect to the culture area, and / or 280 to 1600 μL per 1.0 × 10 ⁷ cells. . This also means that the cell density during the freezing operation may be 6.3 × 10 ^{6 to} 3.6 × 10 ⁷ cells / mL. A person skilled in the art can determine the amount of the culture solution or cryopreservation solution during the freezing operation suitable for the sheet-like cell culture formed with the desired cells without undue experimentation.

  In the production method of the present invention, thawing can be performed by a normal cell thawing method. Typically, for example, a sheet-shaped cell culture frozen while attached to a culture substrate is thawed, for example, Sheet cell culture that has been frozen in a solid, liquid or gaseous medium (eg, water), water bath, incubator, thermostat, etc., or frozen while attached to the culture substrate. This is achieved by immersing the product in a medium (for example, a culture solution) having a temperature higher than the freezing temperature, but is not limited thereto. The temperature of the thawing means or the immersion medium is not particularly limited as long as it is a temperature at which the sheet-shaped cell culture can be thawed within a desired time, but typically 4 to 50 ° C, preferably 30 to 40 ° C, more preferably. Is 36-38 ° C. The thawing time is not particularly limited as long as it does not significantly impair the viability and function of the cells after thawing. In the case of a sheet-like cell culture using myoblasts, it is typically within 2 minutes. In particular, the decrease in the survival rate can be significantly suppressed by setting it within 20 seconds. Here, the thawing time typically means the time until the thawing is completed macroscopically. The completion of the thawing is, for example, when the cell culture that has become cloudy upon freezing is made transparent by thawing. Judgment can be made by The thawing time can be adjusted, for example, by changing the temperature of the thawing means or the immersion medium, the volume or composition of the culture solution or cryopreservation solution at the time of freezing. A person skilled in the art can determine the thawing time suitable for the sheet-like cell culture formed from the desired cells without undue experimentation.

  In the production method of the present invention, the sheet-like cell culture is isolated from the base material by separating (peeling) the sheet-like cell culture from the base material serving as a scaffold while at least partially maintaining the sheet structure. For example, it can be carried out by enzymatic treatment with a proteolytic enzyme (such as trypsin) and / or mechanical treatment such as pipetting. In addition, when cells are cultured on a culture substrate whose surface is coated with a material that changes its physical properties in response to stimulation, for example, temperature or light, a predetermined stimulation is applied. It can also be released non-enzymatically. In particular, when the culture substrate is a temperature-responsive material, sheet-like cells can be obtained only by thawing without performing mechanical treatment such as standing for a long time under a predetermined temperature condition or pipetting. The culture can be isolated.

The production method of the present invention may further include a step of seeding cells on a culture substrate. In a preferred embodiment of the present invention, seeding is performed at a density that allows a sheet-like cell culture to form without substantial growth of the cells. “The density at which cells can form a sheet-shaped cell culture without substantial growth” means that the sheet-shaped cell culture is expressed when cultured in a non-proliferating medium that does not substantially contain growth factors. It means the cell density that can be formed. For example, in the case of skeletal myoblasts, in the conventional method using a culture solution containing a growth factor, cells having a density of about 6,500 cells / cm ² are seeded on a plate in order to form a sheet-like cell culture. However (for example, refer to Patent Document 1), even if cells having such a density are cultured in a culture solution containing no growth factor, a sheet-like cell culture cannot be formed. Therefore, the seeding density in this embodiment is higher than that in the conventional method using a culture solution containing a growth factor. For this reason, in this specification, such seeding density may be simply referred to as “high density”. Specifically, such density is typically 300,000 cells / cm ² or more for skeletal myoblasts, for example. The upper limit of the seeding density is not particularly limited as long as the formation of the cell culture is not impaired and the cells do not shift to differentiation, but for skeletal myoblasts, it is less than 3.4 × 10 ⁶ cells / cm ² .

Accordingly, the “density at which a sheet-like cell culture can be formed without substantially proliferating” in skeletal myoblasts is 3.0 × 10 ^{5 to} 3.4 × 10 ⁶ cells / cm ² in another aspect, 3.5 × 10 ^{5 to} 3.4 × 10 ⁶ pieces / cm ² in the embodiment, 1.0 × 10 ^{6 to} 3.4 × 10 ⁶ pieces / cm ² in still another embodiment, and 3 in another embodiment. 0.0 × 10 ^{5 to} 1.7 × 10 ⁶ pieces / cm ² , in another embodiment, 3.5 × 10 ^{5 to} 1.7 × 10 ⁶ pieces / cm ² , and in another embodiment, 1.0 × 10 ⁶ It is -1.7 * 10 < ⁶ > piece / cm < ² >. As long as an upper limit is less than 3.4 * 10 < ⁶ > piece / cm < ² >, the said range may include both an upper limit and a lower limit, or any one thereof. Therefore, the density is, for example, 3.0 × 10 ⁵ pieces / cm ² or more and less than 3.4 × 10 ⁶ pieces / cm ² (including the lower limit and not including the upper limit), 3.5 × 10 ⁵ pieces / cm 2. ² or more and less than 3.4 × 10 ⁶ pieces / cm ² (including the lower limit, not including the upper limit), 1.0 × 10 ⁶ pieces / cm ² or more and less than 3.4 × 10 ⁶ pieces / cm ² (including the lower limit) , the upper limit is not included), 1.0 × 10 ⁶ cells / cm ² ultra 3.4 × 10 than ⁶ / cm ² (lower limit also contains no upper limit), 1.0 × 10 ⁶ cells / cm ² ultra 1 0.7 × 10 ⁶ pieces / cm ² or less (the lower limit is not included, but the upper limit is included). A person skilled in the art can appropriately determine the cell density suitable for the present invention for cells other than skeletal myoblasts by experiments according to the teaching of the present specification.

  In this embodiment, the cells may or may not proliferate during the culture period, but they do not proliferate to such an extent that the properties of the cells change. For example, skeletal myoblasts start to differentiate when they become confluent, but in the present invention, skeletal myoblasts are seeded at a density that forms a cell culture but does not transition to differentiation. In this embodiment, it is preferable that the cells do not proliferate beyond the measurement error range. Whether or not the cells have proliferated can be evaluated, for example, by comparing the number of cells at the time of seeding with the number of cells after formation of the cell culture. In this embodiment, the number of cells after the formation of the cell culture is typically 300% or less, preferably 200% or less, more preferably 150% or less, even more preferably 125% or less, particularly preferably the number of cells at the time of seeding. Is 100% or less.

The production method of the present invention may further include a step of culturing cells on a culture substrate to form a sheet-shaped cell culture. Cell culture is performed under conditions suitable for the target cells to form a sheet-like cell culture.
In one embodiment of the present invention, cell culture is performed within a predetermined period, preferably within a period in which cells do not shift to differentiation. Thus, in this embodiment, the cells are maintained in an undifferentiated state during the culture period. The transition to cell differentiation can be evaluated by any method known to those skilled in the art. For example, in the case of skeletal myoblasts, MHC expression, creatine kinase (CK) activity, cell multinucleation, myotube formation, etc. can be used as indicators of differentiation. In a preferred embodiment of the present invention, the culture period is within 48 hours, more preferably within 40 hours, and even more preferably within 24 hours.

  The cell culture medium used for the culture (sometimes simply referred to as “culture medium” or “medium”) is not particularly limited as long as it can maintain cell survival, but typically, amino acids, vitamins, electrolytes are used. Can be used. In one embodiment of the present invention, the culture solution is based on a basal medium for cell culture. Such basal media include, but are not limited to, for example, DMEM, MEM, F12, DME, RPMI 1640, MCDB (MCDB102, 104, 107, 131, 153, 199, etc.), L15, SkBM, RITC80-7, and the like. . Many of these basal media are commercially available, and their compositions are also known. As an example, the composition of MCDB131 and DMEM is shown in Table 1 below.

The basal medium may be used in a standard composition (for example, as it is commercially available), or the composition may be appropriately changed depending on the cell type and cell conditions. Therefore, the basal medium used in the present invention is not limited to those having a known composition, and includes one in which one or more components are added, removed, increased or decreased.

Examples of amino acids contained in the basal medium include, but are not limited to, L-arginine, L-cystine, L-glutamine, glycine, L-histidine, L-isoleucine, L-leucine, L-lysine, L-methionine, L-phenylalanine, L-serine, L-threonine, L-tryptophan, L-tyrosine, L-valine and the like are not limited to vitamins, for example, calcium D-pantothenate, choline chloride, folic acid, i - inositol, niacinamide, riboflavin, thiamine, pyridoxine, biotin, lipoic acid, vitamin _{B 12,} adenine, thymidine and then, as the electrolyte, without limitation, for _{example, CaCl 2, KCl, MgSO 4} , NaCl, NaH ₂ PO ₄ , NaHCO ₃ , Fe (NO ₃ ) ₃ , FeS O ₄ , CuSO ₄ , MnSO ₄ , Na ₂ SiO ₃ , (NH ₄ ) 6 Mo ₇ O ₂₄ , NaVO ₃ , NiCl ₂ , ZnSO _{4 and the} like are included. In addition to these components, the basal medium may contain sugars such as D-glucose, pH indicators such as sodium pyruvate and phenol red, putrescine and the like.

In one embodiment of the present invention, the concentration of amino acids contained in the basal medium is as follows: L-arginine: 63.2 to 84 mg / L, L-cystine: 35 to 63 mg / L, L-glutamine: 4.4 to 584 mg / L Glycine: 2.3-30 mg / L, L-histidine: 42 mg / L, L-isoleucine: 66-105 mg / L, L-leucine: 105-131 mg / L, L-lysine: 146-182 mg / L, L -Methionine: 15-30 mg / L, L-phenylalanine: 33-66 mg / L, L-serine: 32-42 mg / L, L-threonine: 12-95 mg / L, L-tryptophan: 4.1-16 mg / L L-tyrosine: 18.1 to 104 mg / L, L-valine: 94 to 117 mg / L.
In one embodiment of the present invention, the concentration of the vitamin preparation contained in the basal medium is as follows: calcium D-pantothenate: 4 to 12 mg / L, choline chloride: 4 to 14 mg / L, folic acid: 0.6 to 4 mg / L , I-inositol: 7.2 mg / L, niacinamide: 4-6.1 mg / L, riboflavin: 0.0038-0.4 mg / L, thiamine: 3.4-4 mg / L, pyridoxine: 2.1- 4 mg / L.

  In addition to the above, the cell culture medium may contain one or more additives such as serum, growth factor, steroid component, and selenium component. However, these components are impurities derived from the manufacturing process that cannot be denied that they can cause side effects such as anaphylactic shock to the recipient in the clinic, and should be excluded in clinical application. Accordingly, in a preferred embodiment of the invention, the cell culture medium does not contain an effective amount of at least one of these additives. In a more preferred embodiment of the present invention, the cell culture medium is substantially free of at least one of these additives. Furthermore, in a particularly preferred embodiment of the present invention, the cell culture medium is substantially free of additives. Therefore, the cell culture medium may contain only the basal medium.

The serum contained in the cell culture medium includes heterologous serum and allogeneic serum. In order to avoid side effects at the time of transplantation, allogeneic serum is preferred, and autologous serum is more preferred.
In one embodiment of the present invention, the cell culture medium is substantially free of serum. A cell culture medium substantially free of serum may be referred to herein as “serum-free medium”. Here, “substantially free of serum” means that the serum content in the culture solution does not have an adverse effect when the cell culture is applied to a living body (for example, the serum albumin content in the cell culture is It means that these substances are not positively added to the culture medium. In the present invention, in order to avoid side effects at the time of transplantation, the cell culture medium preferably contains substantially no heterogeneous serum, and more preferably contains substantially no non-self serum.

  In one embodiment of the invention, the cell culture fluid does not contain an effective amount of growth factor. As used herein, “growth factor” means any substance that promotes cell proliferation as compared to the case without it, such as epithelial cell growth factor (EGF), vascular endothelial growth factor (VEGF), fibroblast, and the like. Cell growth factor (FGF) and the like. In addition, an “effective amount of growth factor” refers to the amount of growth factor that significantly promotes cell proliferation compared to the absence of growth factor, or for the purpose of cell proliferation in the art for convenience. Means the amount usually added. The significance of cell growth promotion can be appropriately evaluated, for example, by any statistical method known in the art, for example, t-test, and the usual addition amount is various in the art. It can be known from known literature. Specifically, the effective amount of EGF in skeletal myoblast culture is, for example, 0.005 μg / mL or more.

  Therefore, “not containing an effective amount of growth factor” means that the concentration of the growth factor in the culture medium of the present invention is less than the effective amount. For example, the concentration of EGF in the culture medium in skeletal myoblast culture is preferably less than 0.005 μg / mL, more preferably less than 0.001 μg / mL. In a preferred embodiment of the present invention, the concentration of the growth factor in the culture solution is less than the normal concentration in the living body. In such an embodiment, for example, the concentration of EGF in the culture medium in skeletal myoblast culture is preferably less than 5.5 ng / mL, more preferably less than 1.3 ng / mL, and even more preferably 0.5 ng / mL. Less than mL. In a further preferred embodiment, the culture medium in the present invention is substantially free from growth factors. Here, “substantially free” means that the content of the growth factor in the culture solution is such that the cell culture is not adversely affected when applied to a living body, and preferably the growth factor is positively added to the culture solution. Means that it is not added. Therefore, in this embodiment, the culture solution does not contain a growth factor at a concentration higher than that contained in other components such as serum.

  In one embodiment of the present invention, the cell culture medium is substantially free of steroid component. Here, the “steroid component” refers to a compound having a steroid nucleus that can adversely affect a living body such as adrenal cortex dysfunction and Cushing's syndrome. Such compounds include, but are not limited to, for example, cortisol, prednisolone, triamcinolone, dexamethasone, betamethasone and the like. Therefore, “substantially free of steroid component” means that the content of these compounds in the culture solution is such that the cell culture is not adversely affected when applied to a living body. This means that these compounds are not actively added, that is, the culture solution does not contain a steroid component at a concentration higher than that contained in other components such as serum.

  In one embodiment of the present invention, the cell culture solution is substantially free of a selenium component. Here, the “selenium component” includes a selenium molecule and a selenium-containing compound, in particular, a selenium-containing compound capable of releasing a selenium molecule in vivo, such as selenite. Therefore, “substantially free of selenium component” means that the content of these substances in the culture solution is such that the cell culture is not adversely affected when applied to a living body. This means that these substances are not actively added, that is, the culture solution does not contain a selenium component at a concentration higher than that contained in other components such as serum. Specifically, for example, in the case of humans, the selenium concentration in the culture solution is the normal value in human serum (for example, 10.6 to 17.4 μg / dL), and the ratio of human serum contained in the medium is It is lower than the multiplied value (that is, if the content of human serum is 10%, the selenium concentration is, for example, 1.0 to less than 1.7 μg / dL).

In the above preferred embodiment of the present invention, impurities derived from production processes such as growth factors, steroid components, and heterogeneous serum components, which have been conventionally required when preparing a cell culture to be applied to a living body, are removed by washing or the like. A process becomes unnecessary. Therefore, one embodiment of the method of the present invention does not include the step of removing impurities derived from the production process.
Here, “manufacturing process-derived impurities” typically include those listed below, which are derived from each manufacturing process. That is, a substance derived from a cell substrate (for example, host cell-derived protein, host cell-derived DNA), a substance derived from a cell culture medium (for example, inducer, antibiotic, medium component), or a step after cell culture It is derived from the extraction, separation, processing, and purification steps of a certain target substance (see, for example, Pharmaceutical Examination No. 571).

Cell culture can be performed under conditions usually used in the art. For example, typical culture conditions include culture at 37 ° C. and 5% CO ₂ . The culture period is preferably within 48 hours, more preferably within 40 hours, and even more preferably within 24 hours, from the viewpoint of sufficient formation of a cell culture and prevention of cell differentiation. Culturing can be performed in containers of any size and shape. In the method of the present invention, since the cells do not substantially proliferate, the cell culture of the desired size and shape can be rapidly transferred without waiting for the cell culture to grow to the desired size as in the conventional method. It becomes possible to get between. The size and shape of the cell culture can be adjusted by adjusting the size and shape of the cell adhesion surface of the culture vessel, or by installing a mold of the desired size and shape on the cell adhesion surface of the culture vessel. It can be arbitrarily adjusted by culturing the cells with, for example.

The method of the present invention can also be positioned as one step of regenerative treatment from cell collection to cell growth and cell culture preparation to cell culture application. Therefore, the present invention
(I) isolating desired cells from tissue or biological fluid collected from the subject,
(Ii) growing the isolated cells;
(Iii) a step of culturing cells on a culture substrate to form a sheet-shaped cell culture; and (iv) freezing the formed sheet-shaped cell culture while attached to the culture substrate. Step (v) Thawing the frozen sheet-shaped cell culture (vi) Step of isolating the sheet-shaped cell culture from the culture substrate, and (vii) Washing the isolated sheet-shaped cell culture The present invention also relates to a method for producing a regenerative treatment sheet-like cell culture comprising steps.

The present invention also relates to a sheet-like cell culture produced by the above production method.
In a preferred embodiment, the sheet-like cell culture of the present invention has sufficient physical strength for washing operations such as immersion stirring and transplantation operations such as removal, holding and transfer. Having sufficient physical strength means that even if the above operation is performed, the sheet-like structure of the cell culture is not impaired. For example, the obtained sheet-like cell culture is actually subjected to the above operation. It can be confirmed by conducting a macroscopic or microscopic investigation that the sheet-like structure is maintained. When a sheet-like cell culture is formed on a culture substrate coated with serum, it usually has sufficient physical strength.

  In a preferred embodiment of the cell culture of the present invention, the cell culture is substantially free of non-autologous serum, growth factors, steroidal agents and / or selenium components. In a more preferred embodiment, the cell culture of the present invention is substantially free of manufacturing process-derived impurities containing the above components. This cell culture can be prepared by culturing cells in a culture medium substantially free of non-autologous serum, growth factors, steroids and / or selenium components to form a cell culture. Here, the cell culture is substantially free of non-autologous serum, growth factors, steroids and / or selenium components, so that the cell culture does not contain these components at concentrations that adversely affect the recipient. At least that means that cell culture can be formed in a culture medium that is substantially free of non-autologous serum, growth factors, steroids and / or selenium components. In a further preferred embodiment, the cell culture of the present invention is substantially free from autologous serum in addition to impurities originating from the manufacturing process. Here, the meaning of “substantially free” is the same as described above.

  In a preferred embodiment of the cell culture of the present invention, the cell culture has reduced inflammatory cytokines. Inflammatory cytokine is a general term for cytokines produced in association with inflammation. Examples thereof include, but are not limited to, TNF-α, IL-1, IL-4, IL-5, IL-6, and IL-13. Can be mentioned. Therefore, “the inflammatory cytokine is reduced” means that the abundance or production (secretory amount) of these cytokines is reduced as compared to differentiated cell cultures. Therefore, the cytokine may exist in any form in the process from gene transcription to protein secretion. For example, the cytokine may exist in the form of a transcript such as mRNA or in the form of a protein. The degree of reduction is not particularly limited as long as it exceeds the error range. For example, it is 15% or more, preferably 25% or more, more preferably 50% or more, and still more preferably 60% compared to differentiated cell culture. % Or more, particularly preferably a reduction of 70% or more.

At the gene level, the amount of cytokine can be any known, for example, Northern blotting method, Southern blotting method, RNase protection assay, PCR method such as RT-PCR, real-time PCR, in situ hybridization method, in vitro transcription method, etc. It can be detected by gene expression analysis, and at the protein level by any known protein detection method such as immunoprecipitation, Western blotting, EIA, ELISA, RIA, immunohistochemistry, immunocytochemistry, etc. . As the specimen, a medium impregnated with a cell culture, a part of the cell culture, or the like can be used.
If such a preferred cell culture is one using skeletal myoblasts, for example, it has a density capable of forming a sheet-like cell culture on a culture substrate coated with serum without substantially growing. It can be obtained by seeding and culturing cells.

  In a preferred embodiment of the invention, the cell culture contains a therapeutically useful physiologically active substance. Such a substance is not particularly limited as long as it has some therapeutic utility, but includes, for example, substances involved in angiogenesis, suppression of cell death, tissue remodeling, cardiac development, stem cell induction, and the like. Specifically, without limitation, for example, VEGF, PIGF, angiogenin, angiopoietin, HGF, PDGF (PDGF-AB, PDGF-BB, etc.), BAG-1, BCL-2, MMP (MMP-2, MMP-3, MMP-9, MMP-10, etc.), TIMP, TNNT2, TNNC1 and the like.

“Contains” these substances means that their abundance or production (secreted amount) can be detected in the cell culture. In a preferred embodiment of the invention, the cell culture contains more of these substances than the differentiated cell culture. The degree of increase is not particularly limited as long as it exceeds the range of error, for example, 1.2 times or more, preferably 1.5 times or more, more preferably 2 times or more, compared to differentiated cell culture, More preferably, it is 3 times or more. These substances may exist in a form in any of the processes from gene transcription to protein secretion. For example, the substance may exist in the form of a transcript such as mRNA or in the form of a protein. The presence of these substances can be detected and / or quantified in the same manner as the above cytokines.
If such a preferred cell culture is one using skeletal myoblasts, for example, it has a density capable of forming a sheet-like cell culture on a culture substrate coated with serum without substantially growing. It can be obtained by seeding and culturing cells.

  In a preferred embodiment of the invention, the cell culture is in an undifferentiated state. The transition to cell differentiation can be evaluated by any method known to those skilled in the art. For example, in the case of skeletal myoblasts, MHC expression, creatine kinase (CK) activity, cell multinucleation, etc. can be used as indicators of differentiation. In addition, since undifferentiated cells have fewer inflammatory cytokines than differentiated cells and there are many therapeutically useful physiologically active substances, the presence or absence of differentiation can also be determined using this as an index. As a technique for obtaining a cell culture in an undifferentiated state, for example, seeding cells having a density capable of forming a sheet-shaped cell culture without substantially growing on a culture substrate, within 48 hours, More preferably, it can be cultured for a period of 40 hours or less, more preferably 24 hours or less.

  The cell culture of the present invention can be used for treatment of a target disease or injury. For example, a cell culture using skeletal myoblasts can be used in the form of a graft for heart diseases such as myocardial infarction and dilated cardiomyopathy. Accordingly, another aspect of the present invention relates to a graft comprising the above cell culture.

The present invention also includes a step of freezing the sheet-shaped cell culture formed on the culture substrate while attached to the culture substrate, and a step of thawing the frozen sheet-shaped cell culture. The present invention relates to a method for promoting isolation of dendritic cell cultures.
The details of each step in this method are as described above for the production method of the present invention. “Promoted isolation” means that the isolation is easier compared to a sheet-shaped cell culture formed on a culture substrate that has not undergone a freeze-thaw step. The separation time was shortened, the damage during isolation was small, the cell recovery rate in the isolated sheet cell culture, that is, the number of cells constituting the isolated sheet cell culture relative to the number of cells seeded It can be evaluated by the fact that the ratio is high, the cell survival rate in the isolated sheet cell culture is high, the mechanical treatment required for detachment and / or the strength of the enzyme treatment is reduced.

  The method may further include a step of seeding cells on the culture substrate. In a preferred embodiment of the present invention, seeding is performed at a density that allows a sheet-like cell culture to form without substantial growth of the cells. The method may further include the step of culturing cells on a culture substrate to form a sheet-like cell culture. The method may further include a step of adding a cryoprotectant to the culture solution or replacing the culture solution with a cryopreservation solution. The details of these steps are as described above for the production method of the present invention.

  The present invention also relates to a sheet-like cell culture that has been frozen while attached to a culture substrate. The details of each term in the present invention are as described above for the production method of the present invention. Since such a sheet-shaped cell culture is attached to a culture substrate, it is easier to produce, store, and move than a frozen frozen sheet-shaped cell culture, and the cell viability after thawing is also high. high. The frozen sheet-like cell culture of the present invention can be obtained by freezing a sheet-like cell culture formed on a culture substrate while attached to the culture substrate. Moreover, the frozen sheet-like cell culture of the present invention may be frozen in a state immersed in a culture solution or a cryopreservation solution containing a cryoprotectant. The method for forming a sheet-shaped cell culture, the freezing method, the thawing method, the isolation method, the cryoprotectant and the cryopreservation solution are as described above for the production method of the present invention.

  Since the frozen sheet-like cell culture of the present invention can be cryopreserved for a long period of time, it is prepared and stored in advance for illness or injury that cannot be predicted when it occurs, and is thawed as necessary. Can be used. In order to avoid rejection, it is advantageous to use a sheet-like cell culture using autologous cells. Therefore, a frozen sheet-like cell culture is prepared from cells collected from a desired subject, and this is used for any subject. If it is stored so that it can be understood, the subject can be treated with the self-sheet cell culture whenever necessary. Thus, the frozen sheet-like cell culture of the present invention makes it possible to construct a sheet-like cell culture bank that stores sheet-like cell cultures from a plurality of subjects.

  The present invention also relates to a culture substrate including a sheet-shaped cell culture frozen in a state of being attached to the surface of the substrate. The details of each term in the present invention are as described above for the production method of the present invention. Such a culture substrate can be used as it is as a storage container for a frozen sheet-like cell culture.

  The present invention also relates to a method for preserving a sheet-shaped cell culture, which comprises a step of freezing a sheet-shaped cell culture formed on a culture substrate while attached to the culture substrate. The details of this process are as described above for the production method of the present invention. The sheet-like cell culture can be preserved directly or in a state where the culture substrate to which it is attached is accommodated in a preservation container. The preservation method is not particularly limited as long as it can maintain a frozen state. For example. The storage temperature is not particularly limited as long as it does not significantly impair the viability and function of cells after thawing, but is typically 0 ° C. or lower, preferably −20 ° C. or lower, more preferably −40 ° C. or lower, and still more preferably Is −80 ° C. or lower. By this method, a sheet-like cell culture can be stored for a long period of time, for example, 3 months or more, 6 months or more, 1 year or more, and further 2 years or more while maintaining a viable cell viability and functionality to withstand practical use. it can.

Hereinafter, the present invention will be further described based on examples, but these examples are illustrative of the present invention and do not limit the present invention.
Comparative Example 1
MCDB131 medium (manufactured by Invitrogen) containing 20% fetal bovine serum (manufactured by Invitrogen), 0.01 μg / ml epidermal growth factor (manufactured by Invitrogen), 4 μg / ml sodium dexamethasone phosphate (manufactured by Schering-Plough) Hereinafter, human skeletal myoblasts (manufactured by Lonza) 3.6 × 10 ⁶ or 9.0 × 10 ⁶ cells are suspended in 1.5 mL of a subculture growth medium), and a Φ3.5 cm cell culture dish (Corning ^(R) 35 mm TC-Treated Culture Dish, Corning). After sowing, the cells were cultured in an incubator at 37 ° C. and 5% CO ₂ for 18 hours. After culturing, the sheet-like cell culture was confirmed after taking out from the incubator and allowing to stand at room temperature for about 60 minutes. As a result, although the formation of a sheet-like cell culture was recognized, when the pipetting operation was performed to peel it from the culture dish, the sheet-like cell culture was broken and could not be recovered (FIG. 1). As described above, since the sheet formed on the culture substrate having normal cell adhesion has stronger adhesion to the culture substrate than the adhesion between cells, the sheet-shaped cell culture is used as the culture substrate. It was clarified that the adhesion between cells could not withstand the pressure applied when it was peeled off, and it was torn.

Comparative Example 2
According to the manufacturing method of the conventional sheet-like cell cultures, the medium for subculture growth 1.5 mL, was suspended human skeletal myoblasts, the Φ3.5cm temperature responsive culture dish ^{(UPCELL (R),} manufactured by Cellseed) 9.0 × 10 ⁶ human skeletal myoblasts were seeded. After sowing, the cells were cultured at 37 ° C. and 5% CO ₂ for 18 hours. After culturing, the sheet-like cell culture was confirmed after taking out from the incubator and allowing to stand at room temperature for about 60 minutes. Formation of a sheet-like cell culture was observed on the culture surface, and the sheet-like cell culture could be recovered from the temperature-responsive culture dish by pipetting operation.

Example 1
Human skeletal myoblasts were suspended in 1.5 mL of subculture medium, and 9.0 × 10 ⁶ cells were seeded on a φ3.5 cm temperature-responsive culture dish (UPCELL®, manufactured by Cellseed ⁾ . After sowing, the cells were cultured at 37 ° C. and 5% CO ₂ for 18 hours. After culturing, after confirming the formation of a sheet-like cell culture on the culture surface, the culture medium for subculture was discarded from the temperature-responsive culture dish and refrigerated at 4 ° C. (serum derived from fetal calf 20% MCDB131 medium (culture medium for subculture) containing 0.01 μg / mL epidermal growth factor and 4 μg / mL dexamethasone sodium phosphate and DMSO (dimethyl sulfoxide, manufactured by Junsei Kagaku) at a ratio of 9: 1 1000 μL each was added and allowed to stand at 2-8 ° C. for 20 minutes. Subsequently, the cryopreservation solution was discarded from the temperature-responsive culture dish, and 500 μL (sheet 1) or 1000 μL (sheet 2) of a new cryopreservation solution was added. After the sheet-like cell cultures were placed in a cryopreservation container temperature responsive culture dish attached ^{(BICELL (R),} manufactured by Nippon freezer), placed in a ultra-low temperature freezer set to cryopreservation container -85 ° C., the sheet The dendritic cell culture was frozen. After 24 hours, the temperature-responsive culture dish was taken out of the ultra-low temperature freezer, and the subculture medium heated to 37 ° C. was added to the temperature-responsive culture dish to rapidly thaw the frozen sheet-like cell culture. As a result, it was possible to easily recover the sheet-like cell culture from the temperature-responsive culture dish without pipetting (FIG. 2).

The obtained sheet-shaped cell culture was dissociated with trypsin-like proteolytic enzyme (TrypLE Select, manufactured by Invitrogen), and then cell count and cell viability were measured. The cell viability was measured as follows. That is, after dissociating cells, the same amount of Trypan Blue Stain 0.4% solution (Invitrogen) was added and mixed, and 10 μL of cell suspension was collected before the cells settled, and a hemocytometer (Elma) was obtained. Injected into. Immediately after the injection, the number of cells observed in the entire 9 mm ² frame of the two chambers of the hemocytometer was measured with an inverted optical microscope (manufactured by Olympus). After the measurement, the average number of viable and dead cells in the two chambers was obtained, and the ratio of unstained cells to the total number of cells including stained cells was calculated. As a result, the cell viability was 97.2% for sheet 1, 96.5% for sheet 2, and the ratio of the number of recovered cells to the number of seeded cells (hereinafter referred to as recovery rate) was 97.6% for sheet 1. 2 was 94.4%, both of which were high. Moreover, the cell viability and the recovery rate tended to improve as the amount of the cryopreservation solution decreased.

Example 2
The passages growth medium 1.5mL suspension of human skeletal myoblasts, cell culture dishes ^{Φ3.5cm (Corning (R) 35mm TC} -Treated Culture Dish, Corning Inc.) by 9.0 × 10 ⁶ cells in Human skeletal myoblasts were seeded. After sowing, the cells were cultured in an incubator at 37 ° C. and 5% CO ₂ for 18 hours. After culturing, after confirming the formation of the sheet-like cell culture on the culture surface, the culture medium for subculture was discarded from the cell culture dish, and 1000 μL of a cryopreservation solution refrigerated at 4 ° C. was added. For 20 minutes. Subsequently, the cryopreservation solution was discarded from the cell culture dish, and a new cryopreservation solution was added at 1000 μL (sheet 3) or 1500 μL (sheet 4). After putting the cell culture dish into a cryopreservation container, the cryopreservation container was placed in an ultra-low temperature freezer set at −85 ° C. to freeze the sheet-shaped cell culture. After 24 hours, the cell culture dish was removed from the ultra-low temperature freezer, and the subculture medium heated to 37 ° C. was added to the cell culture dish to rapidly thaw the frozen sheet-shaped cell culture. When pipetting was performed immediately after thawing, the sheet-like cell culture could be recovered from the cell culture dish. Further, when the obtained sheet-shaped cell culture was dissociated with trypsin-like proteolytic enzyme and then cell count was performed, the cell viability was 94.8% for sheet 3 and 91.0% for sheet 4 and recovered. The rates were 85.4% for sheet 3 and 70.2% for sheet 4, both of which were high enough to withstand practical use.

Example 3
Human skeletal myoblasts are suspended in 1.5 mL of the growth medium for subculture, and 3.6 × 10 ^{6 in} two Φ3.5 cm cell culture dishes (Corning ^(R) 35 mm TC-Treated Culture Dish, Corning). Individual human skeletal myoblasts were seeded. After sowing, the cells were cultured in an incubator at 37 ° C. and 5% CO ₂ for 18 hours. After culturing, after confirming the formation of the sheet-like cell culture on the culture surface, the culture medium for subculture was discarded from the cell culture dish, and 1000 μL of a cryopreservation solution refrigerated at 4 ° C. was added. For 20 minutes. Subsequently, the cryopreservation solution was discarded from the cell culture dish, and 1000 μL of new cryopreservation solution was added. After placing the cell culture dish in a cryopreservation container, the cryopreservation container was placed in an ultra-low temperature freezer set at −85 ° C. to preserve the sheet-shaped cell culture in a frozen state. One cell culture dish was removed from the ultra-low temperature freezer after 24 hours, and the frozen sheet-shaped cell culture was rapidly thawed by adding the subculture medium heated to 37 ° C. to the cell culture dish. The sheet-like cell culture could be recovered by pipetting after thawing. The other cell culture dish was removed from the ultra-low temperature freezer after 3 months and the frozen sheet-shaped cell culture was rapidly thawed by adding the subculture growth medium heated to 37 ° C. to the cell culture dish. . The sheet-like cell culture could be recovered by pipetting after thawing.
From this, it was clarified that the sheet-like cell culture can be stored for a long time by using this method.

Claims (7)

Freezing a sheet-like cell culture formed by culturing cells seeded on a culture substrate for a period of 24 hours or less, while attached to the culture substrate;
Thawing the frozen sheet-shaped cell culture by immersing it in a medium at 30 ° C. to 40 ° C., and isolating the sheet-shaped cell culture from the culture substrate;
A process for producing an isolated sheet-shaped cell culture.   Further comprising seeding the cells on the culture substrate at a density capable of forming a sheet-like cell culture without substantially growing, wherein the density is greater than or equal to the density at which the cells reach confluence. The method of claim 1.   The method according to claim 1 or 2, further comprising a step of culturing cells on a culture substrate to form a sheet-shaped cell culture.   The method according to any one of claims 1 to 3, further comprising a step of adding a cryopreservation agent to the culture solution and / or a step of replacing the culture solution with a cryopreservation solution.   The method in any one of Claims 1-4 with which a culture base material has cell adhesiveness.   The method according to any one of claims 1 to 5, wherein the cell is a skeletal myoblast. Freezing a sheet-shaped cell culture formed by culturing cells seeded on a culture substrate for a period of 24 hours or less while attached to the culture substrate, and a frozen sheet-shaped cell culture A method for promoting the isolation of a sheet-shaped cell culture, comprising a step of thawing by immersing in a medium at 30 ° C to 40 ° C.